Media Thread, page-14580

Now I may not be the sharpest tool in the shed but I notice a few things with your document that a reasonable person would challenge.

Firstly it is old news.
Secondly I would have thought you Mason would know the difference between auto and allo. Even a layman such as myself understand the differences having followed the guidance by senior Imugene staff in multiple presentations.
Thirdly, even the FDA acknowledge that the current benefits outweigh the risks with auto. Imagine how they might react if/when our allo is proven by science to be a lifesaver.